搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
22 小时
Study: Diabetes Drug May Cut Risk of Alzheimer’s and Parkinson’s by 20%
SGLT2 inhibitors, a class of diabetes drugs, may reduce the risk of Alzheimer’s, vascular dementia, and Parkinson’s disease, ...
13 天
治疗MASH新策略!Cell Metabolism揭示降糖药改善代谢功能障碍相关脂肪性 ...
▎药明康德内容团队编辑 代谢功能障碍相关脂肪肝(MASLD)已经成为患病率不断上升的全球性健康问题,而代谢功能障碍相关的脂肪性肝炎(MASH)是MASLD更为严重的阶段,患者会出现肝脏脂质过度堆积、炎症浸润和肝细胞损伤,严重时可导致肝纤维化、肝硬化 ...
earth
1 天
Diabetes drugs may protect against dementia
New research shows diabetes drugs may significantly reduce the risk of dementia, Alzheimer's, and Parkinson’s disease.
生物谷
11 天
张惠杰/杨魏/李晋团队揭示降糖药SGLT2抑制剂改善非酒精性脂肪肝的机制
该研究揭示了SGLT2抑制剂靶向CD8+ T细胞内的酮体代谢以改善MASH的病理生理学机制,为将来SGLT2抑制剂作为“老药新用”的治疗策略提供了一个重要的科学依据。 南方医科大学南方医院张惠杰教授团队联合广东省人民医院杨魏教授及山西医科大学附属第二医院李晋 ...
News Medical on MSN
4 天
SGLT2 inhibitors tied to lower risk of dementia, Parkinson's disease, suggests study
A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a study ...
News Medical on MSN
14 小时
Research reveals disparities in diabetes drug efficacy for Black populations
New research analyzing the effects of two drugs used to treat type 2 diabetes indicates a consistent lack of cardiovascular and renal benefits in Black populations.
McKnight's Long-Term Care News
5 天
SGLT2 inhibitors reduce dementia, Parkinson’s disease risk: study
Sodium-glucose cotransporter-2 (SGLT2) inhibitors, a class of diabetes drugs also known as gliflozins, could lower the risk ...
Medscape
13 天
Do SGLT2 Inhibitors Benefit Everyone With T2D and CKD?
New data suggest that current recommendations overstate the proportion of patients who would receive significant kidney ...
5 天
on MSN
Some Diabetes Drugs May Protect Against Dementia and Parkinson's
Scientists found a 22 percent lower risk of any dementia and Parkinson's among a group taking SGLT2 inhibitors for type 2 ...
Medscape
11 天
SGLT2 Inhibitor Reduces Risk for Neurodegenerative Diseases in T2D
"This was the largest nationwide population-based longitudinal cohort study to investigate the association between the use of ...
GlobalData on MSN
23 天
Diabetes duration has minimal impact on SGLT2 inhibitor efficacy, as per new analysis
A meta-analysis has demonstrated consistent efficacy in heart failure outcomes with SGLT2 inhibitors regardless of disease ...
HealthDay on MSN
4 天
Some diabetes meds might lower risk of dementia, Parkinson's
A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
反馈